Literature DB >> 922252

Evaluation of the uptake of various amines into storage vesicles of intact human platelets.

J L Costa, D L Murphy, J Reveille.   

Abstract

1 The uptake of various 3H-labelled amines into a thrombin-releasable compartment of human platelets, thought to represent the platelet vesicular storage pool, has been evaluated. Measurable amounts of 5-hydroxytryptamine (5-HT), dopamine, tyramine, octopamine, and tryptamine accumulate in this pool, and also in a non-thrombin-releasable (cytoplasmic) pool during a 30 min incubation period with 10(-5) M extracellular amine concentrations. 2 No differences in the accumulation of vesicular or cytoplasmic 5-HT, dopamine, and tyramine are found in platelets treated with deprenyl to inhibit platelet monoamine oxidase as compared to controls. 3 Extracellular tyramine or dopamine in concentrations as high as 10(-5) M does not alter the initial rate of 5-HT uptake across the platelet plasma membrane. Similarly, sizable cytoplasmic pools of either amine do not alter the initial rate at which small amounts of 5-HT enter platelet cytoplasm or storage vesicles. 5-HT thus appears to be the preferred substrate for uptake into platelets and for movement from cytoplasm to vesicles.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 922252      PMCID: PMC1667500          DOI: 10.1111/j.1476-5381.1977.tb08408.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Platelet 5-HT uptake and release stopped rapidly by formaldehyde.

Authors:  J L Costa; D L Murphy
Journal:  Nature       Date:  1975-05-29       Impact factor: 49.962

2.  Changes in human-platelet storage packet size following incubation with labelled serotonin.

Authors:  J L Costa; D L Murphy
Journal:  Life Sci       Date:  1976-06-15       Impact factor: 5.037

3.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

Authors:  C H Donnelly; D L Murphy
Journal:  Biochem Pharmacol       Date:  1977-05-01       Impact factor: 5.858

Review 4.  Blood platelets as a model for monoamine-containing neurones.

Authors:  J M Sneddon
Journal:  Prog Neurobiol       Date:  1973       Impact factor: 11.685

5.  Differential uptake of biogenic amines by isolated 5-hydroxytryptamine organelles of blood platelets.

Authors:  M Da Prada; A Pletscher
Journal:  Life Sci       Date:  1969-01-01       Impact factor: 5.037

6.  Occurrence, transport, and storage of octopamine in human thrombocytes.

Authors:  D L Murphy; D H Cahan; P B Molinoff
Journal:  Clin Pharmacol Ther       Date:  1975-11       Impact factor: 6.875

7.  Demonstration and evaluation of apparent cytoplasmic and vesicular serotonin compartments in human platelets.

Authors:  J L Costa; D L Murphy; M S Kafka
Journal:  Biochem Pharmacol       Date:  1977-03-15       Impact factor: 5.858

8.  A platelet abnormality in the Chediak-Higashi syndrome of man.

Authors:  J L Costa; A S Fauci; S M Wolff
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

9.  Uptake of dopamine by platelets in vivo.

Authors:  D J Boullin; E M McMahon; R A O'Brien
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

  9 in total
  5 in total

1.  Proceedings of the British Pharmacological Society. University of Leicester, 6th-8th July, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

2.  Anomalous compartmentation of 5-hydroxytryptamine in intact human platelets.

Authors:  J L Costa; K L Kirk; D L Murphy; H Stark
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

Review 3.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

4.  Tryptamine transport in rat brain slices: a comparison with 5-hydroxytryptamine.

Authors:  L E Dyck
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

5.  Uptake of 6-fluoro-5-hydroxytryptamine and 4,6-difluoro-5-hydroxytryptamine into releasable and non-releasable compartments of human platelets.

Authors:  J L Costa; K L Kirk; H Stark
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.